Close

CLDN16 Membrane Protein Introduction

Introduction of CLDN16

Claudin-16 is a protein that belongs to the group of claudins. It is encoded by the CLDN16 gene in human. This gene and the CLDN1 gene are clustered on chromosome 3q28. Claudin-16 protein is an integral membrane protein and a component of tight junction strands. It is mainly found in the kidneys, especially in the Henle’s thick ascending limb. Claudin-16 acts as either an intercellular pore or ion concentration sensor to regulate the paracellular resorption of magnesium ions.

Basic Information of CLDN16
Protein Name Claudin-16
Gene Name CLDN16
Aliases Paracellin-1, PCLN-1, PCLN1
Organism Homo sapiens (Human)
UniProt ID Q9Y5I7
Transmembrane Times 4
Length (aa) 305
Sequence MTSRTPLLVTACLYYSYCNSRHLQQGVRKSKRPVFSHCQVPETQKTDTRHLSGARAGVCPCCHPDGLLATMRDLLQYIACFFAFFSAGFLIVATWTDCWMVNADDSLEVSTKCRGLWWECVTNAFDGIRTCDEYDSILAEHPLKLVVTRALMITADILAGFGFLTLLLGLDCVKFLPDEPYIKVRICFVAGATLLIAGTPGIIGSVWYAVDVYVERSTLVLHNIFLGIQYKFGWSCWLGMAGSLGCFLAGAVLTCCLYLFKDVGPERNYPYSLRKAYSAAGVSMAKSYSAPRTETAKMYAVDTRV

Function of CLDN16 Membrane Protein

Claudin-16 protein is critical in tight junction-specific obliteration of the intercellular space by calcium-independent cell-adhesion activity. It is involved in paracellular magnesium reabsorption and is required for selective paracellular conductance. Claudin-16 may form intercellular pores either alone or in combination with other components, which allow the cells of magnesium and calcium ions to pass through their electrochemical gradients. Alternatively, it can be a magnesium concentration sensor that can alter the paracellular permeability mediated by other factors. Defects in CLDN16 gene are responsible for the primary hypomagnesemia, characterized by a large amount of renal magnesium wasting with hypomagnesemia and hypercalciuria, leading to nephrocalcinosis and renal failure. Several diseases are associated with CLDN16, such as hypomagnesemia 3, renal and primary hypomagnesemia. Related pathways include sertoli-sertoli cell junction dynamics and blood-brain barrier and immune cell transmigration: VCAM-1/CD106 signaling pathways.

Fig.1 (A) Genomic organization of CLDN16. Mutations are depicted above the schematic presentation of CLDN16 (novel mutations in bold). (B) Claudin-16 protein model deduced from hydrophilicity plots. (Radulescu, 2013)

Application of CLDN16 Membrane Protein in Literature

  1. Lv F., et al. A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family. Clin Chim Acta. 2016, 457: 69-74. PubMed ID: 27067446

    Authors in this group detected a novel mutation in CLDN16 for the first time. The mutation results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family.

  2. Bardet C., et al. Claudin-16 deficiency impairs tight junction function in ameloblasts, leading to abnormal enamel formation. J Bone Miner Res. 2016, 31(3): 498-513. PubMed ID: 26426912

    The article reveals that claudin-16 deficiency impairs tight junction function in ameloblasts, which leads to abnormal enamel formation. The study indicates the importance of a TJ protein in tooth formation for the first time.

  3. Kladnitsky O., et al. The claudin-16 channel gene is transcriptionally inhibited by 1,25-dihydroxyvitamin D. Exp Physiol. 2015, 100(1): 79-94. PubMed ID: 25557732

    The article indicates that 1,25(OH)2 VitD transcriptionally inhibits the expression of claudin-16 by a mechanism sensitive to Mg2+ and CaSR.

  4. Sikora P., et al. Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations. Nephrol Dial Transplant. 2015, 30(4):636-44. PubMed ID: 25477417

    This article focuses on one of the largest cohorts of FHHNC cases caused by CLDN16 mutations. It shows that familial hypomagnesaemia with hypercalciuria and nephrocalcinosis is due to CLDN16 mutations.

  5. Ikari A., et al. Tight junctional localization of claudin-16 is regulated by syntaxin 8 in renal tubular epithelial cells. J Biol Chem. 2014, 289(19):13112-23. PubMed ID: 24659781

    This article reports that STX8 mediates the recycling of CLDN16, which constitutes a key component of the CLDN16 trafficking machinery in the kidney.

CLDN16 Preparation Options

To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Besides, aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-CLDN16 antibody development services.


As a leading service provider, Creative Biolabs is proud to present our professional service in membrane protein preparation and helps you with the research of membrane proteins. Please do not hesitate to inquire us for more details.

Reference

  1. Konrad M, et al. (2008). CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol. 19(1), 171-81.

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us